Floatz logo

Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid

Prostate Carcinoma

Ivan de Kouchkovsky, MDSmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

107 Active assets in the Prostate Carcinoma cohort.

Asset / SponsorPhaseRating
Leuporelin
Mayo Clinic
Phase 4BBB
Degarelix
Baptist Health South Florida
Phase 3BBB
Enzalutamide
Pfizer
Phase 4BBB
Prednisone
Mayo Clinic
Phase 4BBB
Abiraterone
Mayo Clinic
Phase 4BBB

View all 49 →

Same molecule, other indications

Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid is also rated in:

prostate cancerActive
B
Indicative · Phase 2
56 / 100
View asset →
female reproductive organ cancerActive
CCC
Indicative · Phase 2
53 / 100
View asset →
relapsing-remitting multiple sclerosisActive
CCC
Indicative · Phase 2
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →